Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte. Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here